It is now also recognized that a majority of patients diagnosed with AD also present with cerebral vascular pathology which independently contributes to cognitive decline, with its effects adding to those of core proteinopathies (Aβ, tau) [10, 13, 15, 16]. Here, MAPT is linked to Alzheimer disease.